Translational Cancer Research

Papers
(The H4-Index of Translational Cancer Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Surgical resection of primary tumors improves survival in patients with lung metastases: a population-based SEER analysis38
Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy31
Identifying the risk factors and developing a predictive model for postoperative pelvic floor dysfunction in cervical cancer patients29
A model to guide the management and decision of re-planning during radiotherapy for cervical cancer25
The prognostic biomarker TPGS2 is correlated with immune infiltrates in pan-cancer: a bioinformatics analysis24
CLCN3 in mediating the proliferation of human ovarian cancer cells23
Liver-directed moderately hypo-fractionated radiotherapy combined with pembrolizumab and bevacizumab for advanced hepatocellular carcinoma: a retrospective observational study of 23 cases20
Comprehensive analysis of exosome gene LYPD3 and prognosis/immune cell infiltration in lung cancer20
The analysis of the efficacy and safety of stereotactic body radiotherapy with sequential immune checkpoint inhibitors in the management of oligoprogressive advanced non-small cell lung cancer20
Increase of CD3+CD7− T cells in bone marrow predicts invasion in patients with T-cell non-Hodgkin’s lymphoma18
Effects of a combined treatment regimen consisting of Hsp90 inhibitor DS-2248 and radiation in vitro and in a tumor mouse model18
Effect of caspase-1 (CASP1) combined with multimodal ultrasound features on the prognosis of breast cancer patients18
A recurrent inflammatory myofibroblastic tumor patient with two novel ALK fusions: a case report17
Cervical carcinoma high-expressed long non-coding RNA 1 promotes papillary thyroid carcinoma cell proliferation and invasion16
Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis16
PRSS3 is a potential prognostic biomarker for lung adenocarcinoma15
A fatal multiple-lesion, inflammatory, pseudotumor in the lung: a rare case report15
Acute aortic dissection caused by fruquintinib for metastatic colorectal cancer—a case report and literature review15
Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm15
The size and sternal involvement of chest wall resections for malignant disease predict postoperative morbidity15
0.10308384895325